Hemoglobinopathies Topics-in-Focus program
This program aims to expand awareness and education about increasingly common genetic diseases in Europe among healthcare professionals, patients, and the general population.
The program addresses medical and public health issues in the prevention, early diagnosis, and management of hemoglobinopathies, with a focus on sickle cell disease and beta-thalassemia.
EHA’s initiatives
Some of the content below is restricted to EHA members. To find out more about joining Europe’s biggest hematology community, either as a member or a guest, visit our membership page.
Sickle cell disease courses
To access these items, you must be an EHA member.
- Pathophysiology – cell
- Pathophysiology – vessel
- Pathophysiology – tissue
- Epidemiology & Public Health
- Screening and Diagnosis
- Complications
- Treatment
- Gene Therapy
- Hematology Updates – Sickle Cell Disease
Thalassemia courses
To access these items, you must be an EHA member.
- Fundamentals
- Morbidities
- Family Planning and QoL
- Treatment
- Gene Therapy
- Follow the Iron
- Hematology Updates β-thalassemia
Education programs
To access these items, you must be an EHA member.
Podcasts
- SCD in pregnancy
- Interventions in Adolescent SCD
- Social Stigma and SCD
- Perspectives in SCD – 1
- Perspectives in SCD – 2
- Perspectives in SCD – 3
Videos
- Precision Medicine and hemoglobinopathies
- New Agents for the Treatment of Thalassemia
- TIF Guidelines for transfusion-dependent Thalassemia
Clinical cases
Research
- Specialized Working Group on Red Cells and Iron
- Topics-in-Focus Research Grants
- EHA Research Roadmap on Hemoglobinopathies
Advocacy and alliances
- EHA Position Paper: Access to Affordable Orphan Medicines in Europe
- Thalassaemia International Federation (TIF)
- European Sickle Cell Federation (ESCF)
- European Organisation for Rare Diseases (EURORDIS)
- ERN EuroBloodNet
EU-funded collaborations
- ASCERTAIN consortium (Horizon Europe-funded)
Meetings and events
Relevant articles
- Lancet Haematology Commission SCD
- Gene Therapy of the Hemoglobinopathies
- EHA Research Roadmap on Hemoglobinopathies and Thalassemia
- Precision Medicine and Sickle Cell Disease
- Research in Sickle Cell Disease: From Bedside to Bench to Bedside
Highlights
View highlights from EHA’s pilot preceptorship on sickle cell disease, designed for early-career hematology specialists, clinicians, lab technicians, and pathologists.